Impact of improved upper endoscopy quality on detection of gastric precancerous lesions.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
entrez:
28
1
2023
pubmed:
29
1
2023
medline:
1
2
2023
Statut:
ppublish
Résumé
Intestinal metaplasia (IM) is the point of no return in gastric carcinogenesis, and patients with extensive (antrum plus corpus) IM are at high risk of developing gastric cancer. We evaluated the impact of improved gastroscopy quality on the detection of gastric IM in an Italian area at high risk for gastric cancer. Data of consecutive patients with gastric biopsies according to the updated Sydney System observed in 2013, 2016 and 2019 resulting in IM diagnosis were retrieved. In the first period, endoscopy was performed with standard white light instruments. In the second period, preendoscopic gastric preparation was administered, and the examinations lasting at least 7 min with standard endoscopes were performed. In the third period, the latter procedure was followed, with virtual chromoendoscopy equipped instruments. The prevalence of IM in any gastric site and that of extensive IM were compared among the three periods. Data of 3485 patients were available. The detection of IM in at least one gastric site increased from 29.9 to 33.6% and 34.5% (95% CI, 32.1-36.8) in the first, second and third period, respectively. The difference was statistically significant between the first and last (P = 0.02; OR, 1.24; 95% CI, 1.04-1.48) period. When considering extensive IM, the detection increased from 4.28 to 6.1% and 5.44%, although the difference failed to reach statistical significance (P = 0.076). Our data showed that implementation of a quality protocol increased the probability to detect IM in the stomach, allowing us to select patients deserving stricter follow-up.
Identifiants
pubmed: 36708299
doi: 10.1097/MEG.0000000000002513
pii: 00042737-202303000-00008
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-287Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jamal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71:209–249.
Arnold M, Park J, Camargo MC, Lunet N, Forman D, Soerjomataram I, et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 2020; 69:823–829.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52:6735–6740.
Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007; 12:32–38.
Yue H, Shan L, Bin L. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer 2018; 21:579–587.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51:365–388.
Lahner E, Esposito G, Zullo A, Hassan C, Carabotti M, Galli G, et al. Gastric precancerous conditions and Helicobacter pylori infection in dyspeptic patients with or without endoscopic lesions. Scand J Gastroenterol 2016; 51:1294–1298.
Zullo A, Esposito G, Ridola L, Hassan C, Laehner E, Perri F, et al. Prevalence of lesions detected at upper endoscopy: an Italian survey. Eur J Intern Med 2014; 25:772–776.
Esposito G, Pimentel-Nunes P, Angeletti S, Castro R, Libanio D, Galli G, et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy 2019; 51:515–521.
Bisschops R, Areia M, Coron E, Dabru D, Kaskas B, Kuvaev R, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016; 48:843–864.
Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard DM, et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and association of upper gastrointestinal surgeons of Great Britain and Ireland (AUGIS). Gut 2017; 66:1886–1899.
Donida BM, Tomasello G, Ghidini M, Buffoli F, Grassi M, Ligugli W, et al. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy. BMC Cancer 2019; 19:212.
Manfredi G, Bertè R, Iiritano E, Alicante S, Londoni C, Brambilla G, et al. Premedication with simethicone and N-acetylcysteine for improving mucosal visibility during upper gastrointestinal endoscopy in a Western population. Endosc Int Open 2021; 9:E190–E194.
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161–1181.
Lahner E, Zullo A, Hassan C, Perri F, Dinis-Ribeiro M, Esposito G, et al. Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey. Helicobacter 2014; 19:417–424.
Eidt S, Stolte M. Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol 1994; 29:607–610.
Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33:16–20.
Romańczyk M, Ostrowski B, Budzyń K, et al. The role of endoscopic and demographic features in the diagnosis of gastric precancerous conditions. Pol Arch Intern Med 2022; 132:16200.
Zullo A, Hassan C, Repici A, Annibale B. Intestinal metaplasia surveillance: searching for the road-map. World J Gastroenterol 2013; 19:1523–1526.
Zullo A, Lahner E, Hassan C, Annibale B, Esposito G. Is there an optimal age threshold for searching for intestinal metaplasia on gastric mucosa in Western populations?